From Wikipedia, the free encyclopedia
|
Catumaxomab is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome. |
Stub |
This article has been rated as stub-Class on the quality scale. |
|
[edit] T-lymphocytes
Catumaxomab works by linking the T-lymphocytes with the cancer cells. --Blake3522 08:24, 14 July 2007 (UTC)
- Yes. --Blake3522 10:33, 27 July 2007 (UTC)